Navigation Links
Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
Date:1/6/2009

HAMILTON, Bermuda, Jan. 6 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX) today announced that it has signed an agreement with Dong-A PharmTech Co. Ltd., based in Korea, to develop and market their orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in the United States. Dong-A has successfully completed Phase 2 studies of the product in the United States.

Under the terms of the agreement, Warner Chilcott has exclusive U.S. rights to develop and market the product for the treatment of ED. Dong-A will receive an initial, up-front payment and may also be eligible to receive additional payments upon achievement of certain milestones.

The product was approved by the Korean Food and Drug Administration in December of 2005 for the treatment of ED in Korea under the brand name Zydena. The product was also approved in Russia in July of 2008.

About Warner Chilcott

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare and dermatology segments of the U.S. pharmaceuticals market. The Company is a fully integrated company with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

Read more on http://www.wcrx.com.

Warner Chilcott's Forward Looking Statements:

This press release contains forward-looking statements, including statements concerning our product development efforts. These statements constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The words "may," "might," "will," "should," "estimate," "project," "pl
'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Warner Chilcott to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
2. Warner Chilcott Announces Receipt of Paragraph IV Certification Notices
3. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
4. Warner Chilcott Announces Earnings Release Date and Conference Call for Third Quarter 2008 Financial Results
5. House Passes Historic Bill to Protect Kids From Tobacco; Senators Webb & Warner Should Cosponsor Legislation
6. Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games
7. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
8. Warner Chilcott Announces Settlement of Securities Litigation
9. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
10. CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecoms IP VPN
11. Sharing Miracles Television Program to Feature Mountain Climber and Cancer Survivor Sean Swarner

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...tional Ambassador ,, WHITE PLAINS, N.Y., Nov....ston, Fla., was born so early and with so many und...her he would survive -- or if he would ever walk, ... March of Dimes 2010 National Ambassador. ,, J...inutes of motherhood and I was completely devastat...
(Date:11/9/2009)...this is so, however , , MONDAY, Nov. 9...h very dense breasts have a higher risk of cancer ...ws. , Breast density has already been linked wi...and experts have suspected that very dense breasts...cancer recurrence at the site of the original canc...
(Date:11/9/2009)...ewswire/ -- At a time when the 250,000+ eligible M...rned about finding affordable health insurance, th.... ,, The Today,s Options® Preferred Provid...ides a cost-effective and comprehensive alternativ...an. People with Medicare can choose to sign up fo...
(Date:11/9/2009)...o move lab findings into human therapy for difficu...e damage ,, ANN ARBOR, Mich., Nov. 9 /PRNewswi...f Michigan Department of Neurology have received a... neuropathic pain, a difficult-to-treat condition ...e to nerve without obvious tissue injury. ,, In...
(Date:11/9/2009)...tion industry, respiratory disease, often leading ... major public health concern. Studies led by Debo...ch,s School of Construction, have shown that speci... reducing the dust that causes these health hazard...ology remains very low. , To find out why, Young...
Breaking Medicine News(10 mins):Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3
...roll out Lumina to the Georgia Banker,s Insurance ...., a wholly owned subsidiary of the Georgia Banker...oday a partnership with Atlanta-based North Star H...ates wellness, preventive health, disease manageme...
...Highland Good Steward Management ("HGSM") today an..., a Connecticut-based investment adviser, as a sub...M"), an Alabama-based investment adviser. HGSM f... of K2, said, "K2 and Highland Good Steward Manage...
...rce of Antioxidant Melatonin , , LANSING, Mich., ...n have the unfortunate side effect of disrupting y...t losing even one hour of sleep may affect us for ... the body in small amounts, melatonin plays a role...
...antly improve the safety of methadone, a drug wide...in and other opioid drugs, according to researcher...t. Louis and the University of Washington in Seatt...have been making it difficult for physicians to un...
...hat aspirin inhibited the growth of H. pylori in...d the activity of virulence factors of H. pylori ...y of H. pylori to antimicrlbials including metro...Hospital of China addressed this issue and their r...
...cal example of a malabsorption syndrome conferring...luding folate and vitamin B12. Hyperhomocysteinemi...newly diagnosed coeliac disease than healthy contr...on homocysteine levels in patients with coeliac di...
Other Medicine News:Health News:Paragon Benefits, Inc. Selects North Star Health for Data Analysis and Cost Management Reporting 2Health News:K2 Advisors Named Investment Advisor by Highland Good Steward Management 2Health News:'America's Super Fruit' May Help Reset Body Clock 2Health News:'America's Super Fruit' May Help Reset Body Clock 3Health News:New information points to safer methadone use for treatment of pain and addiction 2Health News:New information points to safer methadone use for treatment of pain and addiction 3Health News:New information points to safer methadone use for treatment of pain and addiction 4Health News:Why does aspirin increase the susceptibility of Helicobacter pylori to antimicrobials? 2Health News:Are vitamin supplements effective in celiac disease patients? 2
(Date:11/9/2009)...swire-Asia/ -- Chindex International, Inc.,("Chind...can provider of Western,healthcare products and se...nounced results for the second quarter and first h.... , , Financial Highlights:, -- Revenue in ...n, flat on, a year over year basis;, -- N...
(Date:11/9/2009)...wire-FirstCall/ -- Caliper Life Sciences, Inc. (Na...vices for drug discovery and life sciences researc...ances and Services (CDAS) unit has been awarded a ...contract with the Environmental Protection Agency ...is new task order increases the cumulative funding...
(Date:11/6/2009)...-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC B...usly approved reverse split of its common stock wi...Nov. 9, 2009 on a 1-for-15 split-adjusted basis. O...r the new symbol OXBT. The stock also will have a ...mes effective. ,, "This reverse split was overw...
Breaking Medicine Technology:Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Caliper Awarded New Task Order for EPA ToxCast Program 2Caliper Awarded New Task Order for EPA ToxCast Program 3Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 53019 1Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 53019 2Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 53019 3Cell Therapeutics Initiates Process to Obtain Marketing Approval for Pixantrone in Europe 53019 4FRC Action Launches TV Ad Campaign On Government Health Care Takeover 53017 1FRC Action Launches TV Ad Campaign On Government Health Care Takeover 53017 2Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line 9403 1Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line 9403 2Fujitsu Expands Support for Ethernet Networks With New Additions to XG Switch Product Line 9403 3
...patient receives ,hidden scar, procedure; Pediatri...m single port surgery with RealHand HD ... July 28 Novare Surgical Systems,announced the su...port,splenectomy, using RealHand HD instruments. T...s doing very well and one day after his surgery wa...
...-Scale Analyses Have Conflicting Results -, CHICA... and thinking processes among placebo groups in Al... ability to show the effectiveness,of new Alzheime...day at the,2008 Alzheimer,s Association Internatio...in Chicago., Alzheimer clinical trials seek to sh...
Other Medicine Technology:Novare Announces Completion of First Pediatric Single Port Spleen Removal Using RealHand(R) HD Instruments 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: